ClinicalTrials.gov record
Completed Phase 3 Interventional

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

ClinicalTrials.gov ID: NCT00000658

Public ClinicalTrials.gov record NCT00000658. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00000658
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
250 participants

Conditions and interventions

Interventions

  • Allopurinol Drug
  • Bleomycin sulfate Drug
  • Cyclophosphamide Drug
  • Cytarabine Drug
  • Dexamethasone Drug
  • Doxorubicin hydrochloride Drug
  • Leucovorin calcium Drug
  • Methotrexate Drug
  • Sargramostim Drug
  • Vincristine sulfate Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Jan 31, 1996
Last update posted
Nov 2, 2021

Ends 1996

United States locations

U.S. sites
22
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
USC CRS Los Angeles California 900331079
UCLA CARE Center CRS Los Angeles California 90095
Ucsf Aids Crs San Francisco California 941102859
University of Colorado Hospital CRS Aurora Colorado 80262
Northwestern University CRS Chicago Illinois 60611
Rush Univ. Med. Ctr. ACTG CRS Chicago Illinois 60612
Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis Indiana 462025250
Johns Hopkins Adult AIDS CRS Baltimore Maryland
Beth Israel Deaconess Med. Ctr., ACTG CRS Boston Massachusetts 02118
Beth Israel Deaconess - East Campus A0102 CRS Boston Massachusetts 02215
Bmc Actg Crs Boston Massachusetts
Washington U CRS St Louis Missouri
SUNY - Buffalo, Erie County Medical Ctr. Buffalo New York 14215
Beth Israel Med. Ctr. (Mt. Sinai) New York New York 02215
NY Univ. HIV/AIDS CRS New York New York 10016
Memorial Sloan-Kettering Cancer Ctr. New York New York 10021
Univ. of Rochester ACTG CRS Rochester New York 14642
Unc Aids Crs Chapel Hill North Carolina 275997215
Case CRS Cleveland Ohio
The Ohio State Univ. AIDS CRS Columbus Ohio 432101228
Hosp. of the Univ. of Pennsylvania CRS Philadelphia Pennsylvania 19104
Pitt CRS Pittsburgh Pennsylvania 15213

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000658, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 2, 2021 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000658 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →